Skip to main content
Novartis
language-selector-globe
Choose Location
  • International
  • Americas
  • Asia Pacific
  • Europe
  • Middle East & Africa
Global | English(link is external)
Novartis Foundation | English(link is external)
Argentina | Español(link is external)
Brazil | Português(link is external)
Canada | English(link is external)
Canada | Français(link is external)
Central America | Español(link is external)
Colombia | Español(link is external)
Mexico | Español(link is external)
United States | English(link is external)
Australia | English(link is external)
Bangladesh | English(link is external)
Hong Kong S.A.R. | 繁體中文(link is external)
India | English(link is external)
Indonesia | English(link is external)
Japan | 日本語(link is external)
Korea | 한국어(link is external)
Mainland China | 中文(link is external)
Malaysia | English(link is external)
Pakistan | English(link is external)
Philippines | English(link is external)
Singapore | English(link is external)
Taiwan | 繁體中文(link is external)
Thailand | ภาษาไทย(link is external)
Austria | Deutsch(link is external)
Belgium | Français(link is external)
Belgium | Nederlands(link is external)
Bulgaria | Български(link is external)
Czech Republic | Česky(link is external)
Czech Republic | English(link is external)
Denmark | Dansk(link is external)
Estonia | Eesti(link is external)
Finland | Suomalainen(link is external)
France | Français(link is external)
Germany | Deutsch(link is external)
Greece | Ελληνικά(link is external)
Hungary | Magyar(link is external)
Ireland | English(link is external)
Italy | Italiano(link is external)
Latvia | Latvian(link is external)
Lithuania | Lithuanian(link is external)
Netherlands | Nederlands(link is external)
Norway | Norsk(link is external)
Poland | Polski(link is external)
Portugal | Português(link is external)
Romania | Română(link is external)
Russia | Русский(link is external)
Serbia | Srpski(link is external)
Slovakia | Slovensky(link is external)
Slovenia | Slovenščina(link is external)
Slovenia | English(link is external)
Spain | Español(link is external)
Sweden | Svenska(link is external)
Switzerland | Deutsch(link is external)
Switzerland | Français(link is external)
Türkiye | Türkçe(link is external)
United Kingdom | English(link is external)
Egypt | English(link is external)
Israel | עברית(link is external)
Saudi Arabia | العربية(link is external)
South Africa | English(link is external)
language-selector-globe
Choose Location
International Americas Asia Pacific Europe Middle East & Africa
Argentina | Español(link is external)
Australia | English(link is external)
Austria | Deutsch(link is external)
Bangladesh | English(link is external)
Belgium | Français(link is external)
Belgium | Nederlands(link is external)
Brazil | Português(link is external)
Bulgaria | Български(link is external)
Canada | English(link is external)
Canada | Français(link is external)
Central America | Español(link is external)
Colombia | Español(link is external)
Czech Republic | Česky(link is external)
Czech Republic | English(link is external)
Denmark | Dansk(link is external)
Egypt | English(link is external)
Estonia | Eesti(link is external)
Finland | Suomalainen(link is external)
France | Français(link is external)
Germany | Deutsch(link is external)
Greece | Ελληνικά(link is external)
Hong Kong S.A.R. | 繁體中文(link is external)
Hungary | Magyar(link is external)
India | English(link is external)
Indonesia | English(link is external)
Ireland | English(link is external)
Israel | עברית(link is external)
Italy | Italiano(link is external)
Japan | 日本語(link is external)
Korea | 한국어(link is external)
Latvia | Latvian(link is external)
Lithuania | Lithuanian(link is external)
Mainland China | 中文(link is external)
Malaysia | English(link is external)
Mexico | Español(link is external)
Netherlands | Nederlands(link is external)
Norway | Norsk(link is external)
Global | English(link is external)
Novartis Foundation | English(link is external)
Pakistan | English(link is external)
Philippines | English(link is external)
Poland | Polski(link is external)
Portugal | Português(link is external)
Romania | Română(link is external)
Russia | Русский(link is external)
Saudi Arabia | العربية(link is external)
Serbia | Srpski(link is external)
Singapore | English(link is external)
Slovakia | Slovensky(link is external)
Slovenia | Slovenščina(link is external)
Slovenia | English(link is external)
South Africa | English(link is external)
Spain | Español(link is external)
Sweden | Svenska(link is external)
Switzerland | Deutsch(link is external)
Switzerland | Français(link is external)
Taiwan | 繁體中文(link is external)
Thailand | ภาษาไทย(link is external)
Türkiye | Türkçe(link is external)
United Kingdom | English(link is external)
United States | English(link is external)
    • About 

      • Board of Directors 

        • Giovanni Caforio 
        • Simon Moroney 
        • Ton Buechner 
        • Patrice Bula 
        • Elizabeth (Liz) Doherty 
        • Ana de Pro Gonzalo 
        • Bridgette Heller 
        • Daniel Hochstrasser 
        • Frans van Houten 
        • Elizabeth McNally 
        • John D. Young 
        • Charlotte Pamer-Wieser 
      • Executive Committee 

        • Vasant (Vas) Narasimhan 
        • Shreeram Aradhye 
        • Victor Bulto 
        • Aharon (Ronny) Gal 
        • Karen L. Hale 
        • Patrick Horber 
        • Harry Kirsch 
        • Rob Kowalski 
        • Steffen Lang 
        • Fiona Marshall 
        • Lutz Hegemann 
        • Kees Roks 
        • Michelle Weese 
      • Products 
      • Therapeutic areas 

        • Cardiovascular, renal and metabolic 
        • Immunology 
        • Neuroscience 
        • Oncology 
      • People and culture 
      • Inclusion 

        • Promoting inclusion 
        • Building belonging 
        • Parental leave 
        • Caring for the mental health and wellbeing of our people 
      • Novartis Gene Therapies 
      • Manufacturing 
      • Quality 

        • Audit program 
        • Novartis quality management system (QMS) 
        • Product and patient safety training 
        • Regulatory inspections 
        • Product recalls 
        • Third-party suppliers 
      • Novartis and the European Union (EU) 
      • Awards and recognition 
      Mother and daughter cuddling on a bed in a kids room

      About

      Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.

    • Patients and caregivers 

      • Novartis commitment to patients and caregivers 
      • Diseases 
      • Patient organization funding 
      • Patients perspectives stories 
      Adult daughter talking to her senior parents on a bench in a park

      Patients and caregivers

      Information for patients and their caregivers including clinical trial recruiting, managed access programs, funding opportunities for patient organizations and side effects reporting.

    • Healthcare professionals 

      • Medical congresses and events 

        • ASCO Annual Meeting 
      • Products 
      • Novartis pipeline 
      • Managed access programs 

        • Zolgensma® Global Managed Access Program (gMAP) 
      • Novartis external funding 
      • Healthcare professional resources by country 
      • Investigator-initiated trials / studies 
      • Novartis medical information 

        • Submit medical enquiry 
      Doctor discussing illness with patient in an office

      Healthcare professionals

      Resources for physicians and other healthcare professionals including clinical trial recruiting, grant funding, congresses and country-level information.

    • Research and development 

      • Technology platforms 
      • Research disease areas 

        • Cardiovascular and metabolic disease research at Novartis 
        • DAx: exploratory disease research at Novartis 
        • Global Health disease area research at Novartis 
        • Immunology disease research at Novartis 
        • Neuroscience research at Novartis 
        • Oncology research at Novartis 
      • Novartis pipeline 
      • Research collaborations 
      • Collaborations 
      A female research scientist in a lab looking at a sample

      Research & development

      Discover how Novartis turns breakthrough science into transformative, high-value treatments.
       

    • ESG 

      • Access 

        • Creating sustainable business models 
        • Value-based pricing 
        • Sub-Saharan Africa 
        • Donations 
        • Novartis access principles 
        • Novartis oncology access 
        • Patents and licensing 
      • Environmental sustainability 

        • Climate 
        • Nature - Waste 
        • Nature - Water 
      • Ethics, risk and compliance 

        • Ethical behavior 
        • Compliance 
        • Human rights 
        • Learning and engagement 
        • Integrated risk assurance 
      • Global health 

        • Pandemic preparedness 
        • Avoidable blindness 
        • Chagas disease 
        • Leprosy 
        • Malaria 
        • Sickle cell disease (SCD) 
        • Novartis Foundation  (link is external)
      • Inclusion 
      • ESG index 
      • Reporting and transparency hub 

        • ESG rating performance 
        • Targets 
        • Patient organization funding 
        • Payments to healthcare professionals 
        • Public policy 
        • A living wage 
        • A safe workplace 
        • Animal research 
      Family and friends having a party at home

      Environmental, social and governance

      Learn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding high ethical standards. Explore the Novartis in Society Integrated Report.

    • Investors 

      • Event calendar 
      • Financial data 

        • Novartis annual results 
        • Novartis quarterly results 
        • Novartis SEC filings 
        • Product sales 
        • Fixed-income securities 
        • Expected currency impact 
      • Share data and analysis 

        • Share monitor 
        • Dividend information 
        • Share ownership 
        • Share overview 
        • Return on investment calculator 
      • Shareholder information 

        • General Meetings 
        • American Depositary Receipts (ADR) 
        • Share buyback 
        • Frequently asked questions 
      • Company overview 

        • Corporate governance 
      • Reporting and transparency hub 

        • Reporting archive 
        • ESG rating performance 
        • Publications order form 
      • ESG 
      Business woman working on her laptop in a bright atmosphere

      Investors

      Updates and resources for investors including financial information, disclosures, events, share price, ESG and reporting.

    • News 

      • Newsroom 
      • Media library  
      • Stories 
      • Subscribe 
      • Events 
      Overhead view of a meeting room with people in the foreground and screens in the background

      News

      Information for journalists including media releases, statements, stories, multimedia resources and more.

    • Careers 

      • Career search 
      • Our business functions 

        • Careers in research and development 
        • Careers in operations 
        • Careers in commercial and sales 
        • Careers in global functions 
      • Why Novartis 
      • Career hub 

        • Temporary contracts  (link is external)
      • Early careers 

        • Graduates 
        • Students 
        • US Biomedical Research internship programs 
        • Community exploration and learning lab (CELL) 
      Two business people

      Careers

      Novartis is hiring! Find open positions, learn more about our strategy and culture, and apply today.

    • Clinical trials 
    • Partnering 
    • Supplier portal 
    • Report side effects 
    • Contacts 
    Grandmother, mother and daughter smiling and laughing on a beach

    Home

    Working together, we can reimagine medicine to improve and extend people’s lives.

Stories

Story Navigation
  • All Topics
    • Discovery
    • From Our Labs
    • Patient Perspectives
    • Access to Healthcare
    • People & Culture
icon
  • 3D rendering of a COVID-19 virus
    Discovery
    COVID-19Disease EradicationInfectious DiseasesWorking at NovartisScientific Research
    Jul 15, 2021

    It takes an R&D village to fight a pandemic

    Gervais Tougas shares his experience working on a Novartis task force dedicated to fighting the COVID-19 pandemic.

    Discovery
  • Coronavirus
    From Our Labs
    COVID-19Disease EradicationInnovationScientific Research
    Jul 20, 2021

    A visual tour of scientific strategies for combating coronavirus

    Researchers around the world are collaborating to provide solutions to immediate and future challenges.

    From Our Labs
  • Europe at night
    People and Culture
    COVID-19DigitalClinical ResearchClinical TrialsClinical ScienceDrug Development
    Aug 10, 2021

    Going the extra mile to keep clinical trials on track during the COVID-19 pandemic

    A Novartis team couriers an experimental treatment across Europe to a patient as transit grinds to a halt.

    People and Culture
  • Transmission electron microscopic image of an isolate from a case of coronavirus disease (COVID-19)
    Discovery
    Biomedical ResearchCOVID-19Data ScienceDiseasesInfectious DiseasesClinical TrialsBiomedical Science
    Jul 14, 2021

    COVID-19: Answering your top questions

    Novartis CEO Vas Narasimhan answers questions about COVID-19.

    Discovery
  • Molecular glues bring proteins together
    Discovery
    Drug DesignInnovationNovartis Institutes for BioMedical ResearchScientific Research
    Sep 27, 2021

    Visualizing molecular glues

    Molecular glues are a new type of medicine inspired by nature’s matchmakers.

    Discovery
  • A heart failure carer discusses their experiences
    Patient Perspectives
    Disease AwarenessDiseasesHeart FailurePatient VoicesDrug Development
    Aug 6, 2021

    Caring for someone with heart failure

    Caring for someone with heart failure can be both demanding and rewarding. Learn about the impact of being a carer and the support that carers need.

    Patient Perspectives
  • Color illustration showing several scientists in front of a large-scale computer highlighting the number 42
    Discovery
    Data ScienceDigitalEmerging TechnologyFuture of HealthcareInnovation
    Jul 14, 2021

    The data42 program shows Novartis’ intent to go big on data and digital

    Novartis is betting on both human inquisitiveness and computer expertise to harness the wealth of its digital research and development platform, data42.

    Discovery
  • Achim Plueckebaum, Peter Speyer and Pascal Bouquet of data42
    Discovery
    Data ScienceDigitalEmerging TechnologyFuture of HealthcareInnovation
    Jul 15, 2021

    Meet Achim, leading the data42 program

    The recently appointed leader of the Novartis’ digital research and development platform data42 is a strong believer that data and digital technologies will change the path of medical science.

    Discovery
  • Doctor examining baby in Rwanda
    People and Culture
    Local ImpactNovartis AccessNovartis Social BusinessWorking at NovartisCareers
    Aug 10, 2021

    Novartis Social Business Careers: improving health in lower income countries

    This is the story of how three Novartis colleagues took a career decision to improve health in lower income countries.

    People and Culture
  • Wendi Yajnik, Global Head of Academic Partnerships and External Innovation for research
    From Our Labs
    Drug DiscoveryEmerging TechnologyInnovationNovartis Institutes for BioMedical ResearchPostdoc Program
    Sep 28, 2021

    Advancing medicine through collaboration

    In Wendi Yajnik’s quest to find new technologies that could transform medicine, relationships are priority No. 1.

    From Our Labs
  • SARS-CoV-2 is the virus that causes coronavirus disease (COVID-19)
    Discovery
    COVID-19Scientific ResearchClinical ResearchClinical Trials
    Jul 13, 2021

    Clinical trial comes together in weeks to address coronavirus

    Researchers race to put hydroxychloroquine to the test in a large study.

    Discovery
  • Alfred and his family
    People and Culture
    Social CommitmentWorking at NovartisCareers
    Aug 10, 2021

    Parental Leave at Novartis: Alfred’s story

    At Novartis, we celebrate life and recognize moments that matter. Alfred Ambatlle shares his experience of parental leave and becoming a father of twins.

    People and Culture

Pagination

  • ‹ Previous page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 33
  • › Next page

Novartis

Working together
  • Patients and caregivers
  • Healthcare professionals
  • Researchers
  • Job seekers
  • Journalists
  • Investors
Topics
  • Pride 2025
  • Access
  • ESG
  • SpeakUp
Explore
  • Pipeline
  • Products
  • Clinical trials
  • Partnering
  • Events
Therapeutic areas
  • Cardiovascular, renal and metabolic
  • Immunology
  • Neuroscience
  • Oncology
  • (link is external)
  • (link is external)
  • (link is external)
  • (link is external)
  • (link is external)
Footer Bottom
© 2025 Novartis AG
  • Terms of use
  • Privacy
  • Cookie settings
  • Contacts
  • Locations
  • Site map
  • Open source
  • Web accessibility
Novartis Site Directory
This site is intended for a global audience